Enhancing the QUAlity and Transparency Of health Research
Search for reporting guidelines
Use your browser's Back button to return to your search results
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR / ACR collaborative recommendations
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Reporting disease activity in clinical trials of rheumatoid arthritis |
| Full bibliographic reference | Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, Bombardieri S, Choi H, Combe B, Dougados M, Emery P, Gomez-Reino J, Keystone E, Koch G, Kvien TK, Martin-Mola E, Matucci-Cerinic M, Michaud K, O'Dell J, Paulus H, Pincus T, Richards P, Simon L, Siegel J, Smolen JS, Sokka T, Strand V, Tugwell P, van der Heijde D, van Riel P, Vlad S, van Vollenhoven R, Ward M, Weinblatt M, Wells G, White B, Wolfe F, Zhang B, Zink A, Felson D. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis. 2008;67(10):1360-1364. |
| Language | English |
| PubMed ID | 18791055 |
| Study design | Clinical trials, Experimental studies |
| Clinical area | Rheumatology |
| Applies to the whole report or to individual sections of the report? | Data, Outcomes (variables) |
| Record last updated on | August 22, 2013 |